<code id='284EE1BC17'></code><style id='284EE1BC17'></style>
    • <acronym id='284EE1BC17'></acronym>
      <center id='284EE1BC17'><center id='284EE1BC17'><tfoot id='284EE1BC17'></tfoot></center><abbr id='284EE1BC17'><dir id='284EE1BC17'><tfoot id='284EE1BC17'></tfoot><noframes id='284EE1BC17'>

    • <optgroup id='284EE1BC17'><strike id='284EE1BC17'><sup id='284EE1BC17'></sup></strike><code id='284EE1BC17'></code></optgroup>
        1. <b id='284EE1BC17'><label id='284EE1BC17'><select id='284EE1BC17'><dt id='284EE1BC17'><span id='284EE1BC17'></span></dt></select></label></b><u id='284EE1BC17'></u>
          <i id='284EE1BC17'><strike id='284EE1BC17'><tt id='284EE1BC17'><pre id='284EE1BC17'></pre></tt></strike></i>

          explore

          explore

          author:explore    Page View:4
          A sign of Humana insurance company on a brick building — business coverage from STAT
          Adobe

          Medicare Advantage beneficiaries on Tuesday filed a class-action lawsuit alleging that the health insurance giant Humana illegally used an algorithm to prematurely cut off payment for rehabilitation care after patients suffered serious illnesses and injuries.

          The suit, filed in U.S. District Court in Western Kentucky, argues Humana’s reliance on the algorithm, known as nH Predict, was part of a fraudulent scheme to reap a windfall by systematically denying claims to desperately ill people.

          advertisement

          It is the second suit filed following a STAT investigation that found Medicare Advantage insurers nationwide are using the algorithm to cut off patients’ rehab care, forcing them to forgo treatment or pay thousands of dollars out of pocket. An earlier complaint was filed in November against the algorithm’s maker, NaviHealth, and the company that owns NaviHealth, UnitedHealth Group.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Crinetics acromegaly drug succeeds in late
          Crinetics acromegaly drug succeeds in late

          AresearcherworkinginthelabatCrineticsPharmaceuticalsinSanDiego.CourtesyCrineticsSANDIEGO—CrineticsPh

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          Covid hospitalizations on the rise, Humana says

          MoreolderadultshavebeenhospitalizedforCovid-19overthepastseveralweeks,accordingtodatareviewedbyhealt